SCHEMBL373175

SCHEMBL373175

C=C(C)C(=O)Oc1cccc(C(c2cccc(OC(=O)C(=C)C)c2)(C(F)(F)F)C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.43
ATM Q13315 2/20 0.38
CYP3A4 P08684 1/20 0.38
LMNA P02545 1/20 0.38
PRSS1 P07477 1/20 0.38
ACR P10323 1/20 0.38
KMT2A Q03164 2/20 0.38
FAAH O00519 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAOB P27338 2/20 0.36
ACHE P22303 1/20 0.36
MAPT P10636 1/20 0.35
MEN1 O00255 1/20 0.35
PPARG P37231 2/20 0.35
PPARA Q07869 1/20 0.35
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29584042 1.00 ELANE (0.43) ELANEATMCYP3A4LMNAPRSS1
SCHEMBL15836532 0.88 ATM (0.48) ELANEATMLMNAPRSS1ACR
SCHEMBL15836493 0.87 ELANE (0.42) ELANEATMCYP3A4LMNAPRSS1
SCHEMBL10431306 0.86 ELANE (0.41) ELANEATMCYP3A4LMNAPRSS1
SCHEMBL28656823 0.83 ELANE (0.40) ELANEATMCYP3A4LMNAPRSS1
SCHEMBL28992157 0.83 ELANE (0.46) ELANEATMCYP3A4LMNAKMT2A
SCHEMBL29584051 0.83 ELANE (0.46) ELANEATMCYP3A4LMNAPRSS1
SCHEMBL373997 0.83 ELANE (0.46) ELANEATMCYP3A4LMNAPRSS1
SCHEMBL373661 0.81 ELANE (0.51) ELANEATMLMNAPRSS1ACR
SCHEMBL218655 0.81 ELANE (0.56) ELANEATMCYP3A4LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346594-B1 SILICONE POLYMER FOR INTRAOCULAR LENSES WITH AMINE GROUPS MENICON CO., LTD. (JP) 2002-02-12 US claimed
EP-0600269-B1 Soft ocular lens material MENICON CO LTD (JP) 1998-02-04 EP claimed
US-5416180-A Fluorine containing (meth)acrylate polymers MENICON CO., LTD. (JP) 1995-05-16 US claimed
EP-0600269-A2 Soft ocular lens material Menicon Co., Ltd. (JP) 1994-06-08 EP claimed
EP-3995493-B1 CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE TOKUYAMA CORP (JP) 2024-07-03 EP disclosed
EP-2657304-B1 AZO DYE, OCULAR LENS MATERIAL, METHOD FOR PRODUCING OCULAR LENS MATERIAL, AND OCULAR LENS MENICON CO LTD (JP) 2022-12-07 EP disclosed
US-20220213050-A1 CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE TOKUYAMA CORPORATION (JP) 2022-07-07 US disclosed
EP-3995493-A1 CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE Tokuyama Corporation (JP) 2022-05-11 EP disclosed
EP-3121643-B1 OPHTHALMIC LENS MENICON CO LTD (JP) 2020-07-22 EP disclosed
US-20180356561-A1 GEL, GEL MANUFACTURING METHOD, LENS, CONTACT LENS SURFACE MODIFIER, POLYMERIZABLE COMPOSITION, AND POLYMER JSR CORPORATION (JP) 2018-12-13 US disclosed
EP-2453292-B1 SOFT HYBRID CONTACT LENS, METHOD FOR PRODUCING SAME, AND HYDRATION METHOD MENICON CO LTD (JP) 2016-09-07 EP disclosed
US-9034942-B2 Polymer material, ophthalmic lens and contact lens MENICON CO., LTD. (JP) 2015-05-19 US disclosed
EP-0381005-B1 Ocular lens material MENICON CO LTD (JP) 1995-01-11 EP disclosed
US-5346946-A Polysiloxane macromonomer MENICON CO., LTD (JP) 1994-09-13 US disclosed
EP-0600269-A2 Soft ocular lens material Menicon Co., Ltd. (JP) 1994-06-08 EP disclosed
EP-0584826-A2 Ocular lens material Menicon Co., Ltd. (JP) 1994-03-02 EP disclosed
EP-0584764-A1 Ocular lens material Menicon Co., Ltd. (JP) 1994-03-02 EP disclosed
EP-0578087-A2 Ocular lens material Menicon Co., Ltd. (JP) 1994-01-12 EP disclosed
US-5041511-A Vinyl benzene acrylate or methacrylate crosslinking agent MENICON CO., LTD. (JP) 1991-08-20 US disclosed
US-4954586-A COPOLYMER OF A FLUORINE CONTAINING (METH)ACRYLATE, AN ALKYL (METH)ACRYLATE, A POLYSILOXANE AND A URETHANE CONTAINING POLYSILOXANE MENICON CO., LTD (JP) 1990-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213050-A1 CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE CRY1, CRY2, TRIP13 ELANE 2505/4885ATM 929/4885CYP3A4 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.